Marc Dean, MD
Otolaryngology · Fort Worth, TXNPI 1730381310
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $441,815 of the $486,242 with a category attached, or 90.9%. Acclarent, Inc accounts for 72.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $183,628 and has fallen 99.4% since, to $1,029 in 2025. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 302 payments — averaging $1610.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acclarent, Inc$353K
- Medical Device Business Services, Inc.$121K
- Biosense Webster, Inc.$9K
- Aerin Medical Inc.$1K
- Spirair, Inc.$522
- Integra Lifesciences Corporation$355
- plus $2K from 15 others
Across 40 payments — averaging $2770.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aerin Medical Inc.$54K
- Sanofi US Services Inc.$42K
- Stryker$12K
- Arrinex, Inc.$2K
What the payments were for
- Consulting fees$441,81591%
- Speaking & faculty fees$7,0001%
- Travel & lodging$30,5266%
- Food & beverage$6,8971%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acclarent, Inc | 163 | $352,860 |
| Medical Device Business Services, Inc. | 81 | $120,656 |
| Biosense Webster, Inc. | 12 | $9,037 |
| Aerin Medical Inc. | 10 | $1,053 |
| Spirair, Inc. | 1 | $522 |
| Integra Lifesciences Corporation | 6 | $355 |
| Stryker | 8 | $304 |
| 3nt Medical | 2 | $253 |
| Medtronic | 3 | $218 |
| 3-d Matrix, Inc. | 2 | $165 |
| Cochlear Americas | 1 | $142 |
| KARL Storz Endoscopy-america | 1 | $120 |
| Gilead | 1 | $107 |
| Johnson & Johnson | 1 | $104 |
| Olympus America Inc. | 1 | $80 |
| Sanofi | 2 | $67 |
| Janssen Scientific Affairs, LLC | 1 | $56 |
| Neurent Medical Limited | 2 | $41 |
| Smith+Nephew | 2 | $40 |
| Xoran Technologies LLC | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACCLARENT Balloon Inflation Device$260,817
- TruDi Nav Suction$120,281
- ACCLARENT NAVWIRE Sinus Navigation Guidewire$82,252
- TruDi Navigation System$77,562
- Acclarent ENT Navigation System$41,917
- TruDi Nav Cable$40,740
- SpinPlus Navigation$38,461
- Acclarent Navwire$10,207
- TruDi$2,695
- ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM$2,310
- SeptAlign$1,045
- TURBALIGN$1,045
- VIVAER STYLUS$461
- RHINAER STYLUS$461
- Acclarent Aera$384
- Cochlear$283
- Inspira Air$261
- RELIEVA SPINPLUS NAV$261
- TruDi Probe$261
- Relieva Ultirra$207
How this compares
$486,242 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 319 | $10,086 |
| Omeprazole | 509 | $8,481 |
| Fluticasone Propionate | 295 | $4,880 |
| Sumatriptan | 12 | $3,033 |
| Budesonide | 19 | $2,413 |
| Azelastine Hcl | 79 | $2,213 |
| Cimetidine | 65 | $1,888 |
| Esomeprazole Magnesium | 56 | $1,411 |
| Mupirocin | 35 | $950 |
| Cefdinir | 45 | $878 |
| Pantoprazole Sodium | 46 | $832 |
| Ondansetron OdtOndansetron | 81 | $680 |
| Doxycycline Hyclate | 46 | $636 |
| Montelukast Sodium | 51 | $559 |
| Gabapentin | 52 | $446 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Fort Worth
- Jeremy WatkinsFort Worth$17K
- Jesse SmithFort Worth$16K
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ronald KuppersmithCollege Station$325K
- Ron KarniHouston$317K
- Philip ChenSan Antonio$305K
- Jordan RihaniSouthlake$280K
- Keith MathenyFrisco$269K
- Martin CitardiHouston$245K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.